Page last updated: 2024-10-22

theophylline and Cardiomyopathy, Hypertrophic

theophylline has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klein, W1

Other Studies

1 other study available for theophylline and Cardiomyopathy, Hypertrophic

ArticleYear
[Hemodynamic effects of a combination of theophylline and ethylenediamine in heart failure with pulmonary hypertension].
    Arzneimittel-Forschung, 1969, Volume: 19, Issue:9

    Topics: Adult; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arteries; Blood Pressure; Cardiac Output;

1969